Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine PCIA in Orthopedic Surgery
ChiCTR2400093106Phase 4Not yet recruiting
- Sponsor
- Henan Cancer Hospital
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in postoperative pain (4 arms), sponsored by Henan Cancer Hospital. Primary endpoint: Patient satisfaction after surgery. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400093106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093106.